Rosuvastatin Completed Phase 4 Trials for Systemic Lupus Erythematosus (SLE) / Thromboembolism / Atherosclerosis Prevention

Indications	Status	Purpose	Phase
DBCOND0038683 (Systemic Lupus Erythematosus (SLE)) DBCOND0022145 (Thromboembolism) DBCOND0022749 (Atherosclerosis)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00371501	Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus	Rosuvastatin (DB01098) Acetylsalicylic acid (DB00945)